Asensus Surgical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Asensus Surgical generated cash of -$63,627,000, which is less than the previous year. Cash used in financing activities reached the amount of $9,626,000 last year. Net change in cash is therefore $10,767,000.
Cash Flow
| 2014 | -33.22M | 4.04M | 53.93M |
|---|---|---|---|
| 2015 | -38.50M | -26.23M | 68.40M |
| 2016 | -52.38M | -1.36M | 49.94M |
| 2017 | -39.79M | -1.99M | 104.37M |
| 2018 | -48.49M | -53.48M | 26.45M |
| 2019 | -73.48M | 67.64M | -5.60M |
| 2020 | -46.67M | -3K | 53.37M |
| 2021 | -40.65M | -119.66M | 161.70M |
| 2022 | -58.93M | 47.53M | -332K |
| 2023 | -63.62M | 64.50M | 9.62M |
ASXC Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 6.32M | 19.28M | 17.52M | 10.56M | 21.65M | 97.60M | 34.59M | 38.44M | 34.76M | 10.01M |
Operating activities | ||||||||||
Net income | -78.43M | -75.56M | -62.46M | -59.31M | -154.20M | -61.77M | -144.79M | -119.98M | -46.94M | -37.65M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.72M | 11.07M | 14.11M | 13.69M | 12.46M | 13.28M | 10.34M | 8.90M | 3.43M | 1.31M |
Stock-based compensation expense | 7.91M | 8.41M | 9.42M | 7.91M | 11.50M | 0 | 7.07M | 5.03M | 3.31M | 1.84M |
| Deferred income tax benefit | 7.91M | 8.41M | 9.42M | 7.91M | 11.50M | 0 | 7.07M | 5.03M | 3.31M | 1.84M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.17M | -1.52M | 174K | -447K | 6.08M | -7.22M | -381K | -1.04M | 133K | 55K |
Inventories | 129K | -2.30M | -611K | -7.19M | -16.40M | -2.14M | -2.98M | -6.64M | -1.92M | 701K |
Accounts payable | 574K | 35K | 1.61M | -1.75M | -668K | 767K | -531K | -356K | 1.09M | -36K |
Cash generated by operating activities | -63.62M | -58.93M | -40.65M | -46.67M | -73.48M | -48.49M | -39.79M | -52.38M | -38.50M | -33.22M |
Investing activities | ||||||||||
Purchases Of Investments | -12.26M | -33.88M | -122.33M | 0 | -12.88M | -55.43M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -561K | -1.27M | -1.36M | -3K | -437K | -770K | -1.99M | -1.36M | -1.23M | -2.17M |
Acquisitions Net | -65.06M | -48.81M | 118.3M | 0 | 15.96M | -5.8M | 0 | 0 | -25M | 0 |
Cash generated by investing activities | 64.50M | 47.53M | -119.66M | -3K | 67.64M | -53.48M | -1.99M | -1.36M | -26.23M | 4.04M |
Financing activities | ||||||||||
Common Stock Issued | 10.11M | 18K | 131.92M | 47.32M | 25.77M | 3.27M | 77.57M | 58.02M | 58.33M | 52.43M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -350K | -1.06M | -36K | -499K | -1.66M | 0 | -168K | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -2.81M | -31.42M | -15.30M | -338K | -6.90M | 9.88M | -2.87M |
Cash used in financing activities | 9.62M | -332K | 161.70M | 53.37M | -5.60M | 26.45M | 104.37M | 49.94M | 68.40M | 53.93M |
Net Change In Cash | 10.76M | -11.81M | 1.75M | 6.96M | -11.08M | -75.95M | 63.01M | -3.85M | 3.68M | 24.75M |
Cash at end of period | 17.09M | 7.47M | 19.28M | 17.52M | 10.56M | 21.65M | 97.60M | 34.59M | 38.44M | 34.76M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |